© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Videos
Better Defining Multiple Sclerosis Categorization: Daniel Ontaneda, MD, PhD
May 11, 2021
The associate professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University discussed the potential of a data-driven approach to classifying patients with MS.
Improving Stroke Discharge Outcomes: Marian LaMonte, MD, MSN, FAAN
May 11, 2021
The chief of neurology at Ascension Saint Agnes discussed the interventions her team implemented to improve patient-specific stroke discharge instructions.
Clinical Utility of Manual Dexterity Test in MS: Marisa McGinley, DO
May 10, 2021
The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed how novel dexterity measurements can improve prognostication of disease progression.
Patient Conversations About Clinical Development in ALS: Matthew B. Harms, MD
May 10, 2021
The associate professor of neurology at Columbia University and medical consultant and care center director at the Muscular Dystrophy Association spoke to the importance of staying up on the latest developments in ALS and keeping patients in the loop on that information.
The Impact of Big Data on ALS Care: Matthew B. Harms, MD
May 09, 2021
The associate professor of neurology at Columbia University and medical consultant and care center director at the Muscular Dystrophy Association discussed the use of larger datasets to improve prognostication and clinical trials in ALS.
Dosage Finding for IMU-838 in Relapsing MS: Robert Fox, MD
May 08, 2021
The Vice-Chair for Research at the Cleveland Clinic Neurological Institute discussed his team’s efforts to find the minimally effective dose of IMU-838.